Oculis Holding AG
OCS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001953530
No open-market purchases or sales by Oculis Holding AG insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $322.0M in total; no superinvestor holds it.
Other share classesOCSAW
13F holders, Q4 2025
Institutional positions in Oculis Holding AG as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +21 vs. Q3 2025
- Shares held
- 18.1M
- +7.18M (+65.9%) vs. Q3 2025
- Total value
- $363.8M
- +$172.1M (+89.7%) vs. Q3 2025
- New holders
- 22
- 9 more added
- Sold out
- 1
- 4 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OCS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $322.0M |
| Q1 2026 | 57 | $534.7M |
| Q4 2025 | 41 | $363.8M |
| Q3 2025 | 20 | $191.7M |
| Q2 2025 | 23 | $99.1M |
| Q1 2025 | 20 | $94.7M |
| Q4 2024 | 12 | $59.4M |
| Q3 2024 | 10 | $36.9M |
| Q2 2024 | 11 | $39.8M |
| Q1 2024 | 9 | $40.9M |
| Q4 2023 | 7 | $44.3M |
| Q3 2023 | 9 | $32.1M |
| Q2 2023 | 9 | $38.5M |
| Q1 2023 | 7 | $23.2M |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Oculis Holding AG; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EQT Fund Management S.a r.l. | 5,900,294 | $117.8M | 10.60% | 00.0% | Unchanged |
| Gildi - lifeyrissjodur | 2,447,985 | $50.3M | 22.73% | +2,447,985 | New |
| Pivotal bioVenture Partners Investment Advisor LLC | 2,288,658 | $45.7M | 17.67% | −12,116−0.5% | Reduced |
| Standard Life Aberdeen plc | 1,746,946 | $34.9M | 0.05% | +493,827+39.4% | Added |
| Wellington Management Group LLP | 1,356,179 | $27.1M | 0.00% | +1,356,179 | New |
| Sr One Capital Management, LP | 641,022 | $12.8M | 1.81% | +318,522+98.8% | Added |
| Saturn V Capital Management LLC | 516,761 | $10.3M | 1.89% | +516,761 | New |
| Nan Fung Group Holdings Ltd | 514,702 | $10.3M | 9.20% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 493,827 | $9.86M | 0.18% | +493,827 | New |
| Alyeska Investment Group, L.P. | 331,332 | $6.62M | 0.02% | +200,000+152.3% | Added |
| Woodline Partners LP | 201,200 | $4.02M | 0.02% | +117,367+140.0% | Added |
| Syquant Capital SAS | 192,722 | $3.85M | 0.47% | +192,722 | New |
| Folketrygdfondet | 182,800 | $3.65M | 0.08% | +182,800 | New |
| Propel Bio Management, LLC | 172,839 | $3.45M | 2.95% | +172,839 | New |
| Citadel Advisors LLC | 165,487 | $3.30M | 0.00% | +165,487 | New |
| NEXTBio Capital Management LP | 149,750 | $2.99M | 1.75% | +149,750 | New |
| Neo Ivy Capital Management | 54,771 | $2.55M | 0.40% | +54,771 | New |
| Compagnie Lombard Odier SCmA | 107,300 | $2.14M | 0.02% | +10,300+10.6% | Added |
| Acuta Capital Partners, LLC | 101,777 | $2.03M | 1.38% | 00.0% | Unchanged |
| Simplify Asset Management Inc. | 98,765 | $1.97M | 0.03% | +98,765 | New |
| Bank of America Corp | 63,951 | $1.28M | 0.00% | +25,416+66.0% | Added |
| Alps Advisors Inc | 46,947 | $937.5K | 0.01% | +46,947 | New |
| UBS Group AG | 45,916 | $916.9K | 0.00% | −28,816−38.6% | Reduced |
| Marshall Wace, LLP | 45,773 | $914.1K | 0.00% | +45,773 | New |
| HRT Financial LP | 43,914 | $876.0K | 0.00% | +43,914 | New |
| Geode Capital Management, LLC | 36,061 | $720.1K | 0.00% | +6,625+22.5% | Added |
| Renaissance Technologies LLC | 25,000 | $499.3K | 0.00% | +25,000 | New |
| Two Sigma Investments, LP | 24,444 | $488.1K | 0.00% | +24,444 | New |
| Northern Trust Corp | 21,189 | $423.1K | 0.00% | −615−2.8% | Reduced |
| Millennium Management LLC | 15,641 | $312.4K | 0.00% | +15,641 | New |
| Gsa Capital Partners LLP | 13,042 | $260.0K | 0.02% | +13,042 | New |
| State Street Corp | 12,519 | $250.0K | 0.00% | +140+1.1% | Added |
| Aventura Private Wealth, LLC | 4,000 | $79.9K | 0.03% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 3,600 | $71.9K | 0.00% | +3,600 | New |
| JPMorgan Chase & Co | 3,180 | $63.5K | 0.00% | +3,180 | New |
| Morgan Stanley | 3,050 | $60.9K | 0.00% | −3,366−52.5% | Reduced |
| China Universal Asset Management Co., Ltd. | 2,000 | $39.9K | 0.00% | +1,000+100.0% | Added |
| Jones Financial Companies LLLP | 210 | $4.19K | 0.00% | +210 | New |
| DuPont Capital Management Corp | 4 | $80 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 1 | $20 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1 | $20 | 0.00% | +1 | New |
| Wolverine Asset Management LLC | 0 | $0 | 0.00% | −269−100.0% | Sold out |